9th Feb '23 by Paul Hill

20 comments 2606 reads

Justin Waite & myself run through 12 new stock purchases, including:

Impact of gas & electricity prices. Start
Markets outlook. 01:50
New stocks Justin has been buying. 07:10
Ashmore. 10:50
Argentex Group PLC. 08:55
ASOS.com. 11:20
Future. 12:10
mjgleeson plc. 12:35
Moneysupermarket Group. 13:35
On the Beach. 15:40
Pets at Home. 16:40
Rightmove 17:30
ScS - Sofa Carpet Specialist. 17:50
Victoria Plumbing Supply. 19:00
Portfolio construction. 19:35
Pfizer. 25:00
How many companies to monitor. 30:15
Investing in generative AI? 32:00
NVIDIA. 35:30
FD Technologies. 36:05
Poolbeg Pharma plc. 38:35
Avingtrans. 40:30
Venture Life Group plc. 43:15
Lords Group Trading. 44:55
XP Factory. 47:55
Polarean Imaging plc. 49:50

Disclosures: As detailed in the video, Justin owns #AGFX #ASHM #ASC #FUTR #GLE #MONY #OTB #PETS #RMV #SCS #VIC #POLB & #XPF. I hold shares in #PFE, #AGFX & #FDP

Unlock with Email

Unlock with Google

Already have an account?
Login here

extrader

9th Feb '23

Interesting that Hill has bought Pfizer (NYQ:PFE) as a boring but safe stock : yes, there's a strong near-term pipeline of new products , but there's also IMO a potentially major reputational risk issue overhanging, viz the gradually emerging story of serious side-effects from the fast-tracked MRNA technology used in the Covid vaccines. The recent 'sting' on a senior research employee being only the tip of the iceberg, AFAICS.

Paul Hill

Thanks extrader - Remember there's side effects from every drug.

Plus just think of all the patient data they've collected (real world) which can be mined going forward to fast track new treatments. Could be a game changer in medical science

Rusty2

Paul, you speak highly of Argentex (LON:AGFX) but you don't hold, was there a reason why you never bought the shares?

I do hold, I was a bit late buying, as was put off by the problems they had a while ago.

Alphaflight

extrader: You are right of course but most people in the UK don't know about this. The legacy media (BBC et al) didn't run the story I believe. Anyway, here it is for anybody that is interested:

Busted Pfizer R&D Exec Claims He Lied About "Mutating COVID" To "Impress A Date Like Normal People"

Source

Quite right! The patient data that hVIVO (LON:HVO) has (going back to 1946/Porton Down etc, from the realisation that UK lost more people in WW2 to flu than to enemy action) is an asset that has yet to be properly commercialised by them. Their Poolbeg Pharma (LON:POLB) spin-off, happily included in your talk, is only part. And of course, they're getting some uniquely detailed info on disease progression from their challenge model studies.

Apologies Rusty I do own Argentex

The Boon Fund

10th Feb '23

Thanks for the video! When I saw the list I was like "hey, many of these are on my watchlist" and I found your commentary on them interesting.

BnB

I enjoyed the sections on portfolio construction and watchlists. Thanks Paul.

Many thanks BnB for the kind words

Likewise Boon - appreciate the feedback

FYI BnB - I highlighted FD Tech's (which I own) KX Insights as being a possible major 'picks & shovels' beneficiary of the exponential growth & important delivery of generative AI (eg ChatGPT) .

When convenient, I'd be interested to hear your thoughts given your expertise in all things tech/software related. Thanks

XTR

If this guy is to be believed and Pfizer are mutating viruses in order to frontrun vaccine demand, then they'll likely see increased revenues. I read somewhere that they are immune from liability on their C19 vaccine, if so litigation is unlikely.

I do know the company. About 15 years ago they were a steady client of my IT consultancy business. They were always very difficult to deal with and when relations eventually broke down we were quite content to move on. That has no bearing on the quality or desirability of their latest technology on which, unfortunately, I'm not in a position to comment. Yet it does explain why I've never investigated in detail since. The re-brand is also a bit of a red flag to me (META!!), although it can certainly be justified in some cases. My other observation is that the share is cheap on an EV/EBITDA basis but expensive on a price to FCF basis. Indeed, this is a business with a history of extremely low FCF margins. That concerns me for reasons an experienced investor like you will immediately grasp. But I expect you are well ahead of me in analysing the accounts and have satisfied yourself the profits are there - or coming soon.

But I do see where you're coming from in respect of KX Insights. The twin worries might be that they - like almost everyone else - are further along with the AI bandwagon in their public relations than in their tech, and that the new tools present a competitor with the opportunity to disintermediate. Equally the proprietary data ought to form a formidable moat.

There's no question that ChatGPT could be a game changer across all industries. I was listening to the conference call of one of my US holdings last night. In a pilot scheme, ChatGPT is making insurance claims on behalf of GPs to gain approval for cardiac treatment, cutting GP admin work to a bare minimum and speeding access to treatment by weeks or even months.

I'm sorry that I can't comment in more detail in this particular case but if you'd like a chat about tech/growth/quality in general offline, happy to share (recently spectacularly unprofitable) thoughts.

AnonymousUser1948090

Be good if these were also available as podcasts as I am out and about quite a lot and could listen in the car, any thought about doing a dual version?

JollyBiologist

No need to read the whole article, but the opening paragraph should reassure you on safety AND efficacy data - look at the sample size! https://www.bmj.com/content/37...

mRNA vaccines absolute miracle of science and with incredibly exciting potential for things like cancer therapy.

Many thanks BnB. Let's see how things develop.

BTW, IMO investors need to value FDP on a SOTP basis (ie 3 separate divisions) - since they're still investing heavily in KX for obviously reasons.

KevinS1

I simply go onto Vox markets, copy the URL, email it to myself and then play it in the car and spend a happy 60 minutes a couple of times a week. A podcast would be easier, but its not the end of the world.

Hi KevinS1, agree it's not the end of the world, I download it currently and convert to MP3

I was just suggesting, if they want to increase their following, then maybe for the convenience of their audience they would offer both as standard, like Tamzin and PI world and Twin Petes on the usual Podcast platforms

11th Feb '23

yes they are on both spotisfy & audioboom

https://www.voxmarkets.co.uk/m...

12 new stock purchases

Unlock the rest of this article with a 14 day trial

About the Author

Paul Hill

20 comments

Busted Pfizer R&D Exec Claims He Lied About "Mutating COVID" To "Impress A Date Like Normal People"

Unlock the metrics for all these stocks and more...

Unlock the metrics for all these stocks and more...